Table 1 |
|||
|
Clinical, histological and radiological scores and plasma levels of IL-6 and VEGF |
|||
|
control rats (n = 8) |
AIA rats (n = 20) |
nor-NOHA treated rats (n = 20) |
|
|
|
|||
|
Body weight (g) |
310 ± 3 |
279 ± 10* |
269 ± 5* |
|
Arthritis score |
0 |
1.3 ± 0.2* |
1.1 ± 0.2* |
|
Ankle diameter (mm) |
7.6 ± 0.1 |
8.3 ± 0.2* |
8.3 ± 0.1* |
|
Histological score |
0 |
4.1 ± |
3.7 ± 1* |
|
Radiological score |
0 |
2.2 ± |
2.1 ± 0.6* |
|
IL-6 (pg/ml) |
366 ± 22 |
419 ± 17* |
378 ± 22 |
|
VEGF (pg/ml) |
488 ± 36 |
642 ± 34* |
500 ± 65 |
|
|
|||
|
Data were obtained 21 days after the onset of arthritis in control rats, AIA rats and nor-NOHA treated rats. Values are the mean ± SEM. * = P <0.05 vs control |
|||
|
Prati et al. Arthritis Research & Therapy 2012 14:R130 doi:10.1186/ar3860 |
|||